Provided by Tiger Trade Technology Pte. Ltd.

Kenvue Inc

17.75
-0.6400-3.48%
Pre-market: 17.780.0300+0.17%09:09 EDT
Volume:24.49M
Turnover:435.53M
Market Cap:34.01B
PE:20.88
High:18.23
Open:18.23
Low:17.67
Close:18.39
52wk High:20.13
52wk Low:14.02
Shares:1.92B
Float Shares:1.89B
Volume Ratio:1.19
T/O Rate:1.29%
Dividend:0.83
Dividend Rate:4.67%
EPS(TTM):0.8500
EPS(LYR):0.7600
ROE:15.58%
ROA:6.99%
PB:3.22
PE(LYR):23.36

Loading ...

Earning Preview: Kenvue Inc this quarter’s revenue is expected to increase by 2.94%, and institutional views are neutral

Earnings Agent
·
Jul 31

Kenvue Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Jul 31

Drugmakers, Retailers Must Face 'maximum Strength' Claim in Decongestant False Ad Litigation in US

Reuters
·
Jul 31

NYSE Order Imbalance 2211216.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 30

Kenvue Increases Quarterly Dividend to $0.21 from $0.2075 a Share; Payable Aug. 26 to Holders of Record Aug. 12

MT Newswires Live
·
Jul 29

Kenvue Maintain Royal Dividend Status with 1.2% Increase

Dow Jones
·
Jul 29

Kenvue Raises Quarterly Dividend to $0.21 a Share

Reuters
·
Jul 29

Kenvue - Declares Qtrly Dividend of $0.21 Per Share, up 1.2% from Prior Dividend

THOMSON REUTERS
·
Jul 29

Kenvue Increases Quarterly Cash Dividend

THOMSON REUTERS
·
Jul 29

Kenvue Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

Kenvue (KVUE) Gains FDA Backing As Valuation Questions Return

Simply Wall St.
·
Jul 26

Kenvue Says FDA Has Granted Tylenol Three-year Exclusivity for New OTC Formulation

Reuters
·
Jul 25

Kenvue - FDA Grants Tylenol Three-year Exclusivity for New Otc Formulation

THOMSON REUTERS
·
Jul 25

Kenvue - Tylenol with Naproxen to be Available Soon at Major U.S. Retailers

THOMSON REUTERS
·
Jul 25

FDA Approves Tylenol® with Naproxen, the First and Only Over-the-counter Fixed-dose Combination of Acetaminophen (650 Mg) and Naproxen Sodium (220 Mg)

THOMSON REUTERS
·
Jul 25

Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?

Simply Wall St.
·
Jul 24

Kenvue's Tylenol With Naproxen Combination Tablet Gets FDA Approval for Pain Relief

MT Newswires Live
·
Jul 24

US FDA - Approves Tylenol with Naproxen, First Otc Acetaminophen/naproxen Combination for 12-hour Pain Relief

THOMSON REUTERS
·
Jul 24

Kenvue Inc. Stock Falls Thursday, Still Outperforms Market

Dow Jones
·
Jul 24

Kenvue to Announce Second Quarter 2026 Results on August 6, 2026

THOMSON REUTERS
·
Jul 23